Home › Funds › MONTANOVA CAPITAL, LLC › FTH
MONTANOVA CAPITAL, LLC position in FTH
FAETH THERAPEUTICS INC
MONTANOVA CAPITAL, LLC reported holding 2,020,103 shares of FTH (FAETH THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$50.5M, representing 0.92% of its reported portfolio and ranking #31 among its reported holdings. MONTANOVA CAPITAL, LLC has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MONTANOVA CAPITAL, LLC's FTH position evolved
MONTANOVA CAPITAL, LLC first disclosed a stake in FTH in Q1 2026 at 34,549 shares (US$1.1M). The position peaked in Q2 2026 at 2,020,103 shares, worth US$50.5M. Across 2 filings, MONTANOVA CAPITAL, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,020,103 shares valued at US$50.5M — an increase of 1,985,554 shares quarter over quarter.. Notable position changes include a 5747% increase in Q2 2026 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 34.55K | $1.09M | New |
| Q2 2026 | 2.02M | $50.50M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About FTH and 13F data
FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 46 other funds we track also report a position in FTH — the largest reported positions include Avoro Capital Advisors LLC (US$36.1M), BAKER BROS. ADVISORS LP (US$32.2M), Fairmount Funds Management LLC (US$18.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTH
- Avoro Capital Advisors LLC 1.44M sh · $36.10M · Q2 2026
- BAKER BROS. ADVISORS LP 1.29M sh · $32.16M · Q2 2026
- Fairmount Funds Management LLC 722.02K sh · $18.05M · Q2 2026
- Logos Global Management LP 722.02K sh · $18.05M · Q2 2026
- Vivo Capital, LLC 722.02K sh · $18.05M · Q2 2026
- Caligan Partners LP 629.47K sh · $15.74M · Q2 2026
- B Group, Inc. 610.17K sh · $15.25M · Q2 2026
- Trails Edge Capital Partners, LP 515.34K sh · $12.88M · Q2 2026
- Octagon Capital Advisors LP 361.01K sh · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M sh · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K sh · $4.51M · Q2 2026
- Patient Square Capital LP 175.05K sh · $4.38M · Q2 2026
More on MONTANOVA CAPITAL, LLC
FAQ
How long has MONTANOVA CAPITAL, LLC held FTH?
MONTANOVA CAPITAL, LLC has disclosed FTH holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MONTANOVA CAPITAL, LLC's current position in FTH?
As of Q2 2026, MONTANOVA CAPITAL, LLC holds 2.02M shares of FTH (FAETH THERAPEUTICS INC), valued at $50.50M, representing 0.92% of its reported portfolio and ranking #31.
Has MONTANOVA CAPITAL, LLC been buying or selling FTH?
In the latest 13F filing (Q2 2026), MONTANOVA CAPITAL, LLC increased its position in FTH. The position peaked in Q2 2026 at 2.02M shares.
Which other funds hold FTH?
Other major institutional holders of FTH include Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, Fairmount Funds Management LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.